CYN vs GILD · rev $249.0K vs P/E 18, rev $7.80B
Cyngn Inc (CYN) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Cyngn Inc (CYN) is a software - application company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported CYN revenue for 2026-06-30 was $249.0K. Net income was -$12.8M. CYN currently screens at market cap $23.8M.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
CYN currently screens at market cap $23.8M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the CYN and GILD stock pages for the full models.
Not investment advice.